A proposal is the latest Obama administration effort to shift medical providers away from a fee-for-service model. » Read More
Intrexon is ready to fight the Zika virus and believes it will get approval to do so in the U.S., its CEO says.
Researchers at MIT have designed an ingestible "robot" that can unfold inside the body, The Verge reports.
Sanofi will nominate eight people to replace the board of Medivation, sources say.
The court case challenges the legality of payments the Obama administration makes to insurers.
Shares of Valeant fell nearly 6 percent after the New York Times reported the company has not kept the discount promises it made to Congress.
There is also strong opposition to speeding up the federal drug approval process, a new poll finds.
The study said when people took acetaminophen, Tylenol's main ingredient, they were less likely to empathize with people experiencing pain. The USAToday reports.
Aetna said it plans to continue its Obamacare health insurance business next year in the 15 states where it now participates, and may expand.
The company's COO is departing as its flagship laboratory operations are threatened with sanctions, The New York Times reports.
Health providers are using malpractice case data to detect potentially worrisome trends in how they deal with patients.
The American goalkeeper tells CNBC she's still concerned about Zika, but decided to "begrudgingly" participate this year's Summer Olympics.
Shares of Zoetis fell Tuesday following a New York Times report that billionaire hedge fund manager Bill Ackman is paring his stake.
Researchers from Harvard University's Wyss Institute have come up with a method to detect the mosquito-borne virus in humans.
Allergan reported a 48 percent rise in quarterly revenue, led by a strong performance by its branded drugs business.
$5,000 prizes will go to the designer of the easiest-to-understand medical bill, and the best transformation of the medical billing system.
Why Apple made the Apple Watch.
The presidential contender's proposals for new spending would cost $33 trillion, but only be financed by $15.3 trillion in new taxes.
Valeant said on Monday it expects to file its first-quarter report with the regulators on or before June 10, ahead of the July 31 deadline.
A new home conception kit offers health insurers a less expensive alternative to pricey fertility treatments.
A new gene test claims it can slow the US painkiller addiction epidemic by identifying likely addicts before a doctor writes a prescription.
Get the best of CNBC in your inbox